Last update 18 Jun 2024

Brilaroxazine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
6-(4-(4-(2,3-Dichlorophenyl)-piperazin-1-yl)-butoxy)-2H-benzo(b)(1,4)oxazin-3(4H)-one, Brilaroxazine Hydrochloride, RP 5000
+ [3]
Mechanism
5-HT1A receptor partial agonists(Serotonin 1a (5-HT1a) receptor partial agonists), 5-HT2A receptor partial agonists(Serotonin 2a (5-HT2a) receptor partial agonists), 5-HT6 receptor antagonists(Serotonin 6 (5-HT6) receptor antagonists)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (US)

Structure

Molecular FormulaC22H25Cl2N3O3
InChIKeyPMKMNTBZJOXTJW-UHFFFAOYSA-N
CAS Registry1239729-06-6

External Link

KEGGWikiATCDrug Bank
-Brilaroxazine-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SchizophreniaPhase 3
US
24 Jan 2022
Acute schizophreniaPhase 2
US
01 Dec 2011
Acute schizophreniaPhase 2
IN
01 Dec 2011
Acute schizophreniaPhase 2
MY
01 Dec 2011
Acute schizophreniaPhase 2
MD
01 Dec 2011
Acute schizophreniaPhase 2
PH
01 Dec 2011
Schizoaffective disorderPhase 2
US
01 Dec 2011
Schizoaffective disorderPhase 2
IN
01 Dec 2011
Schizoaffective disorderPhase 2
MY
01 Dec 2011
Schizoaffective disorderPhase 2
MD
01 Dec 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
feybbxqqre(vgcmzcidyh) = shktbnfhwp wlbuynbsav (jtpxnspfxo )
Met
Positive
30 Oct 2023
Placebo
feybbxqqre(vgcmzcidyh) = jynnialpnh wlbuynbsav (jtpxnspfxo )
Met
Phase 2
234
placebo
jzyaulfgzj(kzmziexmyn) = fbytrmmufm smmfgzgytf (udarhhgxkd, dbbvzpyqaw - stkxprmtvp)
-
26 Jan 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free